Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration

Annals of Surgical Oncology

Volumn 18, Issue 7, 2011, Pages 1837-1844

  Gnerlich, Jennifer L ^a   Deshpande, Anjali D ^a,b   Jeffe, Donna B ^a,b   Seelam, Susmitha ^c   Kimbuende, Eric ^c   Margenthaler, Julie A ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MO   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATTRIBUTABLE RISK; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; IN STAGE MIGRATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MASTECTOMY; PARTIAL MASTECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 80051550853     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1468-3     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
2. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51-7. (Pubitemid 38812422)
3. Stang A, Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treatment. 2008;112:595-6.
4. Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treatment. 2009;115:429-30.
5. Giordano SH. Male breast cancer: it's time for evidence instead of extrapolation. Onkologie. 2008;31:505-6.
6. Ciatto S, Iossa A, Bonardi R, Pacini P. Male breast carcinoma: review of amulticenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori. 1990;76:555-8.
7. Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer. 1994;30A:930-5. (Pubitemid 24256237)
8. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83:498-509. (Pubitemid 28354506)
9. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24:548-52. (Pubitemid 28566902)
10. Tajima N, Tsukuma H, Oshima A. Descriptive epidemiology of male breast cancer in Osaka, Japan. J Epidemiol. 2001;11:1-7. (Pubitemid 33798346)
11. Sandler B, Carmen C, Perry RR. Cancer of the male breast. Am Surg. 1994;60:816-20. (Pubitemid 24345713)
12. Thalib L, Hall P. Survival of male breast cancer patients: population- based cohort study. Cancer Sci. 2009;100:292-5.
13. Borgen PI, Senie RT, McKinnon WMP, Rosen PP. Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann Surg Oncol. 1997:4:385-88. (Pubitemid 127725512)
14. Borgen PI, Wong GY, Vlamis V, et al. Current management of breast cancer: a review of 104 cases. Ann Surg. 1992;215:451-7.
15. Levi F, Randimbison L, La VC. Breast cancer survival in relation to sex and age. Oncology. 1992;49:413-7. (Pubitemid 23003101)
16. Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31A:1960-4. (Pubitemid 26023085)
17. Anan K, Mitsuyama S, Nishihara K, et al. Breast cancer in Japanese men: does sex affect prognosis? Breast Cancer. 2004;11:180-6.
18. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol. 2005;15:773-80. (Pubitemid 41550245)
19. Adami, HO, Holmberg L. Malker B, Ries L. Long-term survival in 406 males with breast cancer. Br J Cancer. 1985;52:99-103. (Pubitemid 15061106)
20. Atalay C, Kanlioz M, Altinok M. Prognostic factors affecting survival in male breast cancer. J Exp Clin Cancer Res. 2003;22:29-33. (Pubitemid 36396654)
21. El-Tamer MB, Komenaka IK, Troxel A, et al. Men with breast cancer have better disease-specific survival than women. Arch Surg. 2004;139:1079-82. (Pubitemid 39362273)
22. National Cancer Institute: Surveillance, Epidemiology, and End Results. Overview of the SEER Program. http://seer.cancer.gov/ about/. Accessed April 21, 2009.
23. Schaub NP, Maloney N, Schneider H, Feliberti E, Perry R. Changes in male breast cancer over a 30-year period. Am Surg. 2008;74:707-12.
24. Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the Veterans Affairs population: a comparative analysis. Cancer. 2007;109:1471-7. (Pubitemid 46595680)
25. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:20-26. (Pubitemid 40165278)
26. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;137:678-687. (Pubitemid 35176102)
27. Temmim L, Luqmani YA, Jarallah M, Juma I, Mathew M. Evaluation of prognostic factors in male breast cancer. Breast. 2001;10:166-75. (Pubitemid 32390235)
28. Rudlowski C, Friedrichs N, Faridi A, et al. Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat. 2004;84:215-23. (Pubitemid 38445371)
29. Avisar E, McParland E, Dicostanzo D, Axelrod D. Prognostic factors in node-negative male breast cancer. Clin Breast Cancer. 2006;7:331-5. (Pubitemid 44717766)
30. Onami S, Ozaki M, Mortimer JE, Pal SK. Male breast cancer: an update in diagnosis, treatment, and molecular profiling. Maturitas. 2010;65(4):308-14.
31. Blin N, Kardas I, Welter C, Rys J, Niezabitowski A, Limon J, et al. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology. 1993;50:408-11.
32. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104:2359-64. (Pubitemid 41691556)
33. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer. 1992;65:252-4.
34. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629-39. (Pubitemid 29075284)
35. Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol. 2002;15:853-61. (Pubitemid 34919778)
36. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232-9.
37. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869-73.
38. Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist. 2001;6:133-146.
39. Wang J, Kollias J, Marsh C, Maddern G. Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand? Breast (Edinburgh). 2009;18:378-81.
40. Gough DB, Donohue JH, Evans MM, Pernicone PJ, Wold LE, Naessens JM, et al. A 50-year experience of male breast cancer: is outcome changing? Surg Oncol. 1993;2:325-33. (Pubitemid 24019851)
41. Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast (Edinburgh). 2007;16: 653-6. (Pubitemid 350154454)
42. Merrill RM, Dearden KA. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States. Cancer Cause Control. 2004;15:1027-34. (Pubitemid 41460295)